LIVN.US LivaNova PLC

Healthcare Health Care Equipment & Supplies USA Stocks
91.32 USD
Close of Nov 15, 2026
52.37 99.38
Market cap
USD 5.03B
P/E
26.2x
P/B
3.67x
ROE
16.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is LIVN.US undervalued?

Graham number
Price91.32
Graham value44.22
Premium106.5%

LIVN.US trades 106.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LivaNova PLC fundamental analysis

No fundamental analysis for LivaNova PLC yet.

LivaNova PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LivaNova PLC

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VN…

Full company profile